ReviewPharmaceutics2023

A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment.

Ana Serrano-Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.